Interventional treatment of noncoronary atherosclerotic pathologies: an update about what the cardiologists should

Gianluca Rigatelli1, Mario Zanchetta

  • 1Department of Cardiovascular Disease, Cittadella General Hospital, Cittadella (PD), Italy. jackyheart@hotmail.com

Insights

Interventional cardiologists are increasingly treating noncoronary atherosclerosis. This review updates cardiologists on new techniques and improved results for systemic vascular conditions.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Vascular Medicine

Background:

  • Atherosclerosis is a systemic disease affecting various vascular beds beyond the coronary arteries.
  • Interventional cardiology is expanding its scope to include noncoronary atherosclerotic pathologies.
  • This involves collaboration between cardiologists, angiologists, and vascular surgeons.

Purpose of the Study:

  • To provide an overview and update on interventional techniques for noncoronary atherosclerosis.
  • To highlight recent advances and outcomes in this evolving field.
  • To equip cardiologists with knowledge of emerging and established interventional strategies.

Main Methods:

  • Review of recent advancements in interventional techniques for noncoronary atherosclerosis.
  • Discussion of new devices and therapeutic approaches.
  • Analysis of outcomes for established procedures like carotid angioplasty and peripheral stenting.

Main Results:

  • Emergence of novel techniques including protection/thromboaspiration devices, atherectomy, cryoplasty, and angiogenic gene therapy.
  • Significant advancements and improved results in established procedures like carotid angioplasty, endovascular aneurysm repair, peripheral brachytherapy, and tibio-peroneal stenting.
  • Growing interest and participation of interventional cardiologists in treating these noncoronary conditions.

Conclusions:

  • Interventional cardiologists play an expanding role in managing systemic atherosclerosis.
  • Numerous innovative techniques and refined established procedures offer improved outcomes for noncoronary vascular diseases.
  • Staying updated on these advances is crucial for comprehensive patient care in interventional cardiology.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...